GILD Expands Trodelvy Approval
Gilead's Trodelvy receives FDA approval for unresectable locally advanced or metastatic triple-negative breast cancer
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.